Targeted therapy with phosphodiesterase 5 inhibitors in patients with pulmonary hypertension due to heart failure and elevated pulmonary vascular resistance: a systematic review

Pulmonary Hypertension due to left heart disease is the most common type of Pulmonary Hypertension. Morbidity and mortality significantly increase once Pulmonary Hypertension is present. Treatment is aimed toward optimizing the underlying condition. Targeted therapy has been evaluated in small studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez Palacios, Galo M., Schmidt, Cindy, Wichman, Tammy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545768/
https://www.ncbi.nlm.nih.gov/pubmed/33088478
http://dx.doi.org/10.1177/2045894020948780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545768/
https://www.ncbi.nlm.nih.gov/pubmed/33088478
http://dx.doi.org/10.1177/2045894020948780

Ejemplares similares